Mounjaro slovenia price 2026?

Do I have a price for Mounjaro in Slovenia in 2026?
The available public data do not include a 2026 price for Mounjaro (tirzepatide) in Slovenia. Pricing for new medicines in Slovenia is set by the Slovenian Health Insurance Fund and can change annually. Because the drug was only approved in the EU in 2022, any 2026 price would be a future estimate that has not yet been released.

How does Slovenia determine drug prices?
The Health Insurance Fund negotiates prices with manufacturers and may reference international prices or reimbursement thresholds. The decision reflects both clinical benefit and budget impact. Once a price is agreed, it is published in the official Slovenian drug price registry.

When might a 2026 price become available?
Price updates typically appear in the annual budget cycle, usually in the spring of each year. If Mounjaro is listed for reimbursement, an updated price for 2026 would likely be published in the 2025/2026 budget documents or the national drug price list.

Where can I find official price listings?
Check the Slovenian Health Insurance Fund’s website or the national drug price registry. These portals publish the current reimbursed price for each medicine. For historical prices, the “Drug Price History” section may list past values.

Is there a reference price for Mounjaro worldwide?
Globally, Mounjaro has been priced between $1,500 and $2,500 per month in the United States and the UK. Prices vary by country based on negotiations and local reimbursement schemes. Slovenia will likely adopt a price within this range, adjusted for its purchasing power and healthcare budget.

What to do if you need an exact figure?
Contact the Slovenian Health Insurance Fund directly or consult the latest national drug price list. If the price has not yet been released, the fund can provide an estimate or indicate when the next update is expected.